ArticleMemorias do Instituto Oswaldo Cruz2026
Differential expression of miRNAs in Vero cells after Mayaro virus infection.
Article in Memorias do Instituto Oswaldo Cruz, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe Mayaro virus (MAYV) is an alphavirus endemic to Central and South America, primarily transmitted by mosquitoes of the Haemagogus genus. Human infection causes "Mayaro fever," characterized by symptoms similar to dengue and chikungunya, including debilitating arthralgia. Despite its potential for urbanisation, many aspects of MAYV-host interactions, particularly the role of host microRNAs (miRNAs), remain poorly understood.
objectivesThis study aimed to investigate the expression profile of miRNAs in Vero cells infected with MAYV and to predict their potential biological targets and associated pathways.
methodsInfection was performed using the MAYV strain (BeAr 20290), and small RNA libraries were prepared from infected and control cells. Initial experiments were conducted to evaluate viral replication, cell viability, and small RNA expression. Based on these parameters, the 24-h post-infection time point was selected for small RNA sequencing. Bioinformatic tools were used to identify differentially expressed miRNAs and predict their targets in Homo sapiens and the MAYV genome.
findingsAmong the 348 miRNAs identified, 46 were differentially expressed at 24 h (42 upregulated and four downregulated). Principal component analysis (PCA) indicated a clear separation between infected and control groups. In silico predictions of the targets of these miRNAs suggest potential associations with biological processes that may be relevant to virus-host interactions, such as immune response, programmed cell death pathways, viral replication, and persistence. Additionally, one miRNA detected in Vero cells was predicted to target a viral non-structural protein. MAIN
conclusionsOur findings indicate a potential dual role for host miRNAs during MAYV infection, involving both the modulation of host responses by the virus to enhance replication and a possible antiviral effect. While these interactions underscore the prospective relevance of miRNAs as biomarkers and therapeutic targets in arboviral infections, it is important to note that these conclusions are based solely on computational analyses. Therefore, they should be interpreted with caution until they are supported by further experimental validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.